Conformational restrictions activity

VI. Conformationally Restricted Active-Site-Directed Enzyme Inhibitors... 

VI. CONFORMATIONALLY RESTRICTED ACTIVE-SITE-DIRECTED ENZYME INHIBITORS... 

In order to give useful information about an enzyme, a conformationally restricted active-site-directed analog inhibitor need not bind to the enzyme irreversibly. In a study of the enzyme fructose 1,6-diphosphatase from rabbit liver, Benkovic et al, have investigated the question of the reactive form of the fructose 1,6-diphosphate in the enzymatic process (104,105). Three likely forms are shown in structures 50, 51 and 52. 

Cromakalim (137) is a potassium channel activator commonly used as an antihypertensive agent (107). The rationale for the design of cromakalim is based on P-blockers such as propranolol (115) and atenolol (123). Conformational restriction of the propanolamine side chain as observed in the cromakalim chroman nucleus provides compounds with desired antihypertensive activity free of the side effects commonly associated with P-blockers. Enantiomerically pure cromakalim is produced by resolution of the diastereomeric (T)-a-meth5lben2ylcarbamate derivatives. X-ray crystallographic analysis of this diastereomer provides the absolute stereochemistry of cromakalim. Biological activity resides primarily in the (—)-(33, 4R)-enantiomer [94535-50-9] (137) (108). In spontaneously hypertensive rats, the (—)-(33, 4R)-enantiomer, at dosages of 0.3 mg/kg, lowers the systoHc pressure 47%, whereas the (+)-(3R,43)-enantiomer only decreases the systoHc pressure by 14% at a dose of 3.0 mg/kg. 

Probing the Active Sites of Enzymes with Conformationally Restricted Substrate Analogs. BY G. L. KENYON AND J. A. FEE, Department of Chemistry, University of California, Berkeley, California. 381... 

Probing the Active Sites of Enzymes With Conformationally Restricted Sutetrate Analogs... 

Substrate analogs which promise to be particularly good active-site probes are those which are conformationally restricted. One key feature of enzymatic processes is that when a substrate is bound to an enzyme, probably only one of the many possible conformations of the substrate molecule is assumed. Consequently, before a detailed mechanism for an enzymatic process can be formulated, the preferred conformations of each of the enzyme-bound substrates must be known. ... 

In conclusion, one must be aware of these limitations on the use of locked substrate analogs. The problems encountered in the study of a-chymotrypsin are perhaps more severe than for most other enzymes, since a-chymotrypsin normally acts on large, polymeric substrates and is relatively nonspecific. The active site of a-chymotrypsin therefore potentially can bind small substrates such as D24 in a variety of ways. Ideally, larger conformationally restricted substrates should give more information about the active site of a-chymotrypsin. However, besides the increased problems involved in synthesizing these larger substrates, there is the problem of increased possibility of uncertainty in their conformations. 

GABAc receptors are defined by their insensitivity to bicuculline and their activation by conformationally restricted analogues of GABA such as CACA and (+)-CAMP (15, 2i -2-(aminomethyl)cyclopropanecarboxylic acid). They are blocked by picrotoxin but can be selectively antagonised by TPMPA (l,2,5,6-tetrahydropyridin4-ylphosphinic acid). Unlike GABAa receptors, they are not affected by benzodiazepines, barbiturates or anaesthetics (Barnard et al. 1998 Bormann 2000 Chebib and Johnston 2000). 

Application of the concept of conformational restriction to opioid peptides has produced fruitful results, insofar as peptide analogues and mimetics with interesting opioid activity profiles and high stability against enzymatic... 

Captopril 678 and enalapril 679 are potent angiotensin converting enzyme (ACE) inhibitors used as antihypertensives. Molecular manipulation based on the enzyme model led to the discovery of some perspective bicyclic structures, for example, cilazapril 680 and compound 681, highly active antihypertensives in vivo. Compound 681 belongs to the most potent conformationally restricted ACE inhibitors and is often used as a model for molecular modeling studies <1996JA8231>. 

Table 6.22. IN VITRO ACTIVITY OF CONFORMATIONALLY RESTRICTED 1-PHENYLQUINOLONES [96]...

Teleocidines are known as tumor-promoting compounds characterized by an indolactam V core structure. Such indolactams adopt two stable conformations at room temperature. With the intention to investigate the biologically active conformer, Irie and Wender synthesized conformationally restricted analogs of indolactam V 50 (R=Me) [17]. Starting from desmethylindolactam... 

An Italian team reported that pyridazinones (89) hydroxymethylated at C-5 induced a high decrease in systolic blood pressure in rats [371]. In Italy, much effort has been devoted also to the preparation of conformationally restricted congeners of antihypertensive pyridazinones. In a structure-activity study, it has been found that indeno[l,2-c]pyridazinones, in particular compounds (90), are potent antihypertensive agents [372]. 

We examined the effect of restricted conformation on the activation entropy by kinetic studies at various temperatures [34]. Three kinds of substrates were subjected to the reaction phenylmalonic acid as the standard compound, ortho-chlorophenylmalonic acid as a substrate with an electron-withdrawing group, and indane-l,l-dicarboxylic acid as a conformationally restricted compound. The initial rates of the enzymatic decarboxylation reaction of three compounds were measured at several substrate concentrations at 15 °C, 25 °C, and 35 °C. The kcat and values at each temperature were obtained by a Lineweaver-Burk plot,... 

---